
Dr Lincoln Tan is a consultant urologist and accredited robotic surgeon with a subspecialty interest in prostate cancer diagnosis, risk stratification and minimally invasive treatment. He has extensive experience in managing prostate conditions and carrying out prostate biopsies, with a clinical approach focused on achieving accurate diagnosis while avoiding unnecessary procedures.
Dr Tan places a strong emphasis on listening to his patients' concerns and addressing their individual needs. By taking time to connect with his patients and understand their needs, he helps to provide a personalised and thoughtful approach to care, guiding them through diagnosis and treatment with a sense of compassion.
Dr Tan places a strong emphasis on listening to his patients' concerns and addressing their individual needs. By taking time to connect with his patients and understand their needs, he helps to provide a personalised and thoughtful approach to care, guiding them through diagnosis and treatment with a sense of compassion.
Dr Lincoln Tan's clinical work in Singapore has focused on improving how prostate conditions are diagnosed and managed, with a focus on making care more accurate, accessible and efficient for patients.
Dr Tan was the principal investigator of the first local study validating the Prostate Health Index (phi), helping to refine prostate cancer risk stratification. This has contributed to more precise decision-making, reducing unnecessary biopsies while ensuring that clinically significant cancers are detected early.
Dr Tan was also among the early clinical leaders who introduced free-hand, office-based transperineal prostate biopsy techniques to Singapore. This technique has helped move prostate biopsy away from more invasive hospital-based procedures towards a safer, more efficient in-clinic approach with lower infection risk and improved patient comfort.
Across his practice, Dr Tan adopts a fuss-free, patient-centred approach to urology. He focuses on delivering quick and efficient diagnosis, with consultation-to-biopsy completed within 48 hours where appropriate. Procedures are carried out fully in-clinic without the need for hospitalisation, helping to reduce waiting time, avoid unnecessary costs and minimise disruption for patients.
